Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments. |
Learning Objective: Illustrates potential market failures for new drug development in epilepsy market and shows novel organizational vehicle to commercialize greater innovation from epilepsy research. |
8.25.2007
NeuroTherapy Ventures: Catalyzing Neurologic Innovations
NeuroTherapy Ventures: Catalyzing Neurologic Innovations: "
"